Host-tumour interplay in Tasmanian devils with devil facial tumour disease: can immune cells be harnessed for therapy? Tasmanian devils only exist naturally in Tasmania and Devil Facial Tumour Disease, an infectious cancer, could cause the extinction of the Tasmanian devil. This project will determine if Devil Facial Tumour Disease reduces the effectiveness of the devil's immune system and test if activated immune cells can protect against this disease.
Development of an amoebic gill disease vaccine to protect Atlantic salmon. This project aims to identify candidate vaccine antigens and produce an experimental vaccine against amoebic gill disease (AGD) that will benefit the Tasmanian and international Atlantic salmon aquaculture industries. AGD is the most significant health problem affecting Atlantic salmon aquaculture in Tasmania. In the last decade, AGD has become a legitimate health threat to the multibillion dollar global Atlantic salmon i ....Development of an amoebic gill disease vaccine to protect Atlantic salmon. This project aims to identify candidate vaccine antigens and produce an experimental vaccine against amoebic gill disease (AGD) that will benefit the Tasmanian and international Atlantic salmon aquaculture industries. AGD is the most significant health problem affecting Atlantic salmon aquaculture in Tasmania. In the last decade, AGD has become a legitimate health threat to the multibillion dollar global Atlantic salmon industry. A solution is needed before AGD fully establishes itself in the largest Atlantic salmon producing nations. The expected outcome of this project is the development of a commercial vaccine that should significantly benefit the Australian and international aquaculture industries. Read moreRead less
Development of an immune enhancing vaccine to protect Tasmanian devils against a contagious cancer. The iconic Tasmanian devil is threatened with extinction from a uniformly fatal transmissible facial cancer. Our team has shown in proof of concept that the cancer cells can be recognised by the devil immune system. This project will develop and test a vaccine against the tumour, which will ultimately protect devils in the wild.
Discovery Early Career Researcher Award - Grant ID: DE180100484
Funder
Australian Research Council
Funding Amount
$365,058.00
Summary
Tipping the balance from tolerance to immunity for the devil facial tumour. This project aims to develop a single-shot vaccine for the Tasmanian devil facial tumour disease. The disease is an enigma because the transmissible tumours are simultaneously cancer, infections, and genetically mismatched tissue grafts. This project will focus on immune molecules that are revolutionising human oncology, and will develop techniques to understand and systematically test the function of these key molecules ....Tipping the balance from tolerance to immunity for the devil facial tumour. This project aims to develop a single-shot vaccine for the Tasmanian devil facial tumour disease. The disease is an enigma because the transmissible tumours are simultaneously cancer, infections, and genetically mismatched tissue grafts. This project will focus on immune molecules that are revolutionising human oncology, and will develop techniques to understand and systematically test the function of these key molecules in Tasmanian devils. Understanding the role of these immune molecules will accelerate development of a vaccine to help save the devil and has the potential to shed light on general principles relating to how the immune system balances tolerance and immunity.Read moreRead less
Immunisation to protect against transmissible cancers in Tasmanian devils. This project aims to identify the immune escape mechanisms that the transmissible cancers, Devil Facial Tumour Disease (DFTD) use to avoid being killed by the immune system. Since the discovery of the second transmissible cancer (DFT2) mystery surrounds whether the devils immune system can respond to this cancer, hence this project will investigate the immune response to DFT2. The final aims are to develop a vaccine with ....Immunisation to protect against transmissible cancers in Tasmanian devils. This project aims to identify the immune escape mechanisms that the transmissible cancers, Devil Facial Tumour Disease (DFTD) use to avoid being killed by the immune system. Since the discovery of the second transmissible cancer (DFT2) mystery surrounds whether the devils immune system can respond to this cancer, hence this project will investigate the immune response to DFT2. The final aims are to develop a vaccine with the potential to protect healthy devils and cure devils with DFTD.Read moreRead less
An immunological and immunogenetic approach to understand and to protect Tasmanian devils against Devil Facial Tumour Disease. The Tasmanian devil is the world's largest living carnivorous marsupial. From an environmental perspective, devils play a fundamental role through scavenging. Dead and dying animals were removed nightly from Tasmania's landscape and therefore decaying carcases did not require removal. Loss of this top order scavenger will alter the balance of biodiversity and non-native ....An immunological and immunogenetic approach to understand and to protect Tasmanian devils against Devil Facial Tumour Disease. The Tasmanian devil is the world's largest living carnivorous marsupial. From an environmental perspective, devils play a fundamental role through scavenging. Dead and dying animals were removed nightly from Tasmania's landscape and therefore decaying carcases did not require removal. Loss of this top order scavenger will alter the balance of biodiversity and non-native animals (such as foxes, feral cats, crows, and even European wasps) will then compete for this scavenger role. As these animals are non-selective they will also prey on living animals and many of Tasmania's native animals (such as Eastern barred bandicoot, potoroos, quolls etc.) will be seriously threatened and our biodiverse landscape could be irreversibly altered.Read moreRead less
Improving the diagnosis, management and control of chlamydial infections in Australian livestock. Chlamydial diseases, such as arthritis and encephalomyelitis, are associated with significant economic losses for Australian livestock producers. Effective surveillance and management of Chlamydia infections is problematic due to: the absence of epidemiological data; the lack of an accurate and easily interpretable diagnostic test; and the lack of an available vaccine. This project aims to evaluate ....Improving the diagnosis, management and control of chlamydial infections in Australian livestock. Chlamydial diseases, such as arthritis and encephalomyelitis, are associated with significant economic losses for Australian livestock producers. Effective surveillance and management of Chlamydia infections is problematic due to: the absence of epidemiological data; the lack of an accurate and easily interpretable diagnostic test; and the lack of an available vaccine. This project aims to evaluate factors associated with chlamydial disease in Australian livestock and thereby improve on-farm diagnosis. With the concomitant development of a chlamydial vaccine for sheep, this project aims to provide veterinarians and producers with important tools to reduce the on-farm impacts of chlamydial disease.Read moreRead less
Developing a chlamydial vaccine for koalas. Developing a chlamydial vaccine for koalas . This project aims to produce an optimised, safe, field-tested, protective Chlamydia vaccine for koalas. In many regions of Australia, Chlamydia infection severely reduces female koala reproductive rates, threatening the species’ long term survival. This project builds on work developing a prototype vaccine for koala Chlamydia, and intends to produce a vaccine ready for potential registration and use by koala ....Developing a chlamydial vaccine for koalas. Developing a chlamydial vaccine for koalas . This project aims to produce an optimised, safe, field-tested, protective Chlamydia vaccine for koalas. In many regions of Australia, Chlamydia infection severely reduces female koala reproductive rates, threatening the species’ long term survival. This project builds on work developing a prototype vaccine for koala Chlamydia, and intends to produce a vaccine ready for potential registration and use by koala care centres, wildlife hospitals and government departments.Read moreRead less
Mitigating ecosystem impacts by improving the way we breed and manage devils. The Tasmanian ecosystem faces irreversible change due to the decline of the apex predator. An insurance population of Tasmanian devils has been established to prevent extinction of the species. Using the latest sequencing technologies the project aims to determine whether the Tasmanian ecosystem can be restored with Tasmanian devils that are more resilient to a changing environment by improving the way that devils are ....Mitigating ecosystem impacts by improving the way we breed and manage devils. The Tasmanian ecosystem faces irreversible change due to the decline of the apex predator. An insurance population of Tasmanian devils has been established to prevent extinction of the species. Using the latest sequencing technologies the project aims to determine whether the Tasmanian ecosystem can be restored with Tasmanian devils that are more resilient to a changing environment by improving the way that devils are bred and managed in captivity.Read moreRead less
Developing a wildlife health intelligence and vaccine distribution system. This project aims to establish an industry-linked pipeline for vaccines to be delivered to animals in edible baits and a near real-time monitoring system for assessing the impact of management actions. This project will develop ultrasensitive diagnostic tests and incorporate biomarkers into baits from Australia's leading pest animal control company. Bait uptake and disease status in the field will be monitored using artif ....Developing a wildlife health intelligence and vaccine distribution system. This project aims to establish an industry-linked pipeline for vaccines to be delivered to animals in edible baits and a near real-time monitoring system for assessing the impact of management actions. This project will develop ultrasensitive diagnostic tests and incorporate biomarkers into baits from Australia's leading pest animal control company. Bait uptake and disease status in the field will be monitored using artificial intelligence technology developed in Tasmania. This integrated wildlife health intelligence and scalable vaccine platform can help protect the iconic Tasmanian devil from disease and increase Australia's preparedness for looming threats to the livestock industry such as African swine fever.Read moreRead less